statistiche ricercatore

SPANEVELLO, ANTONIO

Distribuzione geografica

Continente	#
NA - Nord America	25.404
EU - Europa	10.846
AS - Asia	8.524
SA - Sud America	1.080
Continente sconosciuto - Info sul continente non disponibili	679
AF - Africa	219
OC - Oceania	49
Totale	46.801

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	24.977
IT - Italia	5.385
SG - Singapore	2.737
CN - Cina	2.164
UA - Ucraina	1.554
VN - Vietnam	1.101
HK - Hong Kong	989
BR - Brasile	871
TR - Turchia	689
SE - Svezia	649
GB - Regno Unito	613
IE - Irlanda	553
DE - Germania	471
FI - Finlandia	460
FR - Francia	396
RU - Federazione Russa	308
BD - Bangladesh	306
CA - Canada	182
MX - Messico	123
IN - India	122
NL - Olanda	122
NG - Nigeria	100
AR - Argentina	75
AT - Austria	74
JP - Giappone	71
IQ - Iraq	41
PL - Polonia	41
ID - Indonesia	38
AU - Australia	36
ZA - Sudafrica	33
EC - Ecuador	31
PK - Pakistan	31
BE - Belgio	30
ES - Italia	30
SA - Arabia Saudita	28
CO - Colombia	26
KR - Corea	26
CR - Costa Rica	23
CZ - Repubblica Ceca	23
MY - Malesia	23
MA - Marocco	22
VE - Venezuela	22
CL - Cile	19
CH - Svizzera	18
HN - Honduras	17
UZ - Uzbekistan	17
AE - Emirati Arabi Uniti	15
PE - Perù	15
JM - Giamaica	14
TT - Trinidad e Tobago	14
TW - Taiwan	14
LT - Lituania	13
RO - Romania	13
NP - Nepal	12
NZ - Nuova Zelanda	12
DZ - Algeria	11
EU - Europa	11
HU - Ungheria	11
KZ - Kazakistan	11
MD - Moldavia	11
TH - Thailandia	11
JO - Giordania	10
KE - Kenya	10
PH - Filippine	10
PT - Portogallo	9
PY - Paraguay	9
SV - El Salvador	9
AL - Albania	8
AZ - Azerbaigian	8
EG - Egitto	8
NO - Norvegia	8
OM - Oman	8
SK - Slovacchia (Repubblica Slovacca)	8
TN - Tunisia	8
BO - Bolivia	7
DK - Danimarca	7
GT - Guatemala	7
IR - Iran	7
NI - Nicaragua	7
BG - Bulgaria	6
GP - Guadalupe	6
GR - Grecia	6
PR - Porto Rico	6
BB - Barbados	5
EE - Estonia	5
IL - Israele	5
SN - Senegal	5
BH - Bahrain	4
CI - Costa d'Avorio	4
LK - Sri Lanka	4
PA - Panama	4
UY - Uruguay	4
BA - Bosnia-Erzegovina	3
BY - Bielorussia	3
KH - Cambogia	3
LB - Libano	3
LY - Libia	3
MM - Myanmar	3
SC - Seychelles	3
ZM - Zambia	3
Totale	46.091

Salva come PNG Salva come JPEG

Città	#
Milan	3.476
Fairfield	2.338
Ashburn	2.197
San Jose	2.054
Woodbridge	1.832
Singapore	1.467
Jacksonville	1.265
Houston	1.220
Ann Arbor	1.207
Chandler	1.101
Council Bluffs	1.009
Hong Kong	974
Seattle	936
Wilmington	931
Cambridge	788
Dallas	587
Dublin	534
Princeton	533
Shenzhen	467
Dearborn	411
Boardman	386
The Dalles	381
Izmir	372
Beijing	319
Chicago	317
Nyköping	314
Rome	311
Dong Ket	285
Lauterbourg	284
New York	250
Santa Clara	230
Ho Chi Minh City	191
Los Angeles	183
San Diego	176
London	153
Hanoi	137
Como	126
Helsinki	123
San Mateo	120
Ogden	105
São Paulo	101
Abuja	95
Phoenix	89
Washington	83
Mexico City	80
Hefei	77
Munich	70
Guangzhou	69
Falls Church	58
Tokyo	58
Toronto	58
Naples	54
Atlanta	53
Orem	52
Kocaeli	49
Shanghai	49
San Francisco	48
Columbus	46
Brooklyn	45
Salt Lake City	45
Nanjing	44
Nuremberg	43
Buffalo	42
Frankfurt am Main	41
Vienna	41
Amsterdam	40
Kunming	39
Montreal	37
Norwalk	37
Chennai	34
Warsaw	34
Philadelphia	32
Rio de Janeiro	32
San Genesio Ed Uniti	32
Tianjin	30
Verona	30
North Bergen	28
Hangzhou	27
Jinan	26
Tampa	25
Brussels	24
Zhengzhou	24
Dhaka	23
Düsseldorf	23
Redmond	23
Haiphong	22
Las Vegas	22
Redwood City	22
Boston	21
Charlotte	21
Da Nang	21
Catania	20
Denver	20
Bari	19
Belo Horizonte	19
Elk Grove Village	19
Miami	19
Stockholm	19
Johannesburg	18
Magnago	18
Totale	32.480

Salva come PNG Salva come JPEG

Nome	#
Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis	605
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases	336
Airway inflammation in patients affected by obstructive sleep apnea	320
The effects of a cognitive behavioural intervention in asthmatic patients.	312
Classifying new anti-tuberculosis drugs: rationale and future perspectives	261
Five-year survival of stage IIIA-IIIB (non-N3) non-small cell lung cancer patients after platinum/gemcitabine induction chemotherapy and surgery	261
A European Respiratory Society technical standard: exhaled biomarkers in lung disease	257
Six-Minute Walking Distance Improvement after Pulmonary Rehabilitation Is Associated with Baseline Lung Function in Complex COPD Patients: A Retrospective Study	253
Aging and airway inflammation	240
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis	240
Aging and induced-sputum cells	238
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study	237
Brittle Asthma	227
Models of respiratory infections: Virus-induced asthma exacerbations and beyond	226
3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.	225
A new Editorial Board of Monaldi Archives for Chest Disease	225
Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome	223
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases	223
Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy	222
A pilot study of nurse-led, home monitoring for patients with chronic respiratory failure and with mechanical ventilation assistance	220
Therapeutic drug monitoring: How to improve drug dosage and patient safety in tuberculosis treatment	219
Clinical and operational value of the extensively drug-resistant tuberculosis definition	218
Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation	218
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial	218
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use	218
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients.	215
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB	213
Menopausal asthma: a new biological phenotype?	212
History of tuberculosis and drug resistance	211
Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD	210
Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD	210
Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey	210
Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis	208
Bronchoalveolar lavage causes decrease in PaO2, increase in (A-a) gradient value and bronchoconstriction in asthmatics	207
Markers of airway inflammation in pulmonary diseases assessed by induced sputum.	207
Induced sputum to assess airway inflammation: a study of reproducibility	206
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials	206
When kidneys and lungs suffer together	206
Tuberculosis elimination: theory and practice in Europe	205
AIDS and tuberculosis control programmes: an integrated approach at educational level.	204
Airway responsiveness to methacholine: effects of deep inhalations and airway inflammation.	203
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB	203
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results	203
Exhaled NO and iNOS expression in sputum cells of healthy, obese and OSA subjects	203
Microsatellite alterations suggestive of organ-specific asthma and atopy in exhaled breath condensate	202
Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study	201
Ripped from the headlines: how can we harness communications to control TB?	201
Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.	201
Improving the TB case management: The International Standards for Tuberculosis Care	201
Exhaled matrix metalloproteinase-9 (MMP-9) in different biological phenotypes of asthma	201
Economic analysis of two structured treatment and teaching programs on asthma	200
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae	200
Tele-assistance in Chronic Respiratory Failure Patients: a Randomised Clinical Trial.	198
Effect of methacholine challenge on cellular composition of sputum induction	198
Bronchial hyperresponsiveness, airway inflammation, and reversibility in patients with chronic obstructive pulmonary disease	198
Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity	197
European union standards for tuberculosis care	197
Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults	196
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD	196
Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance	196
Sputum induced cellularity in a group of traffic policemen	194
Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8	194
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis	194
In vitro susceptibility testing and totally drug-resistant tuberculosis	194
Tuberculosis elimination: Where are we now?	193
Comparison of two methods of processing induced sputum: selected versus entire sputum	192
Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance.	192
Airway inflammation in patients affected by obstructive sleep apnea syndrome.	192
Latex allergy and sensitization in cities: a survey in a population at risk	192
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution	192
Effects of intradermal injection of atrial natriuretic peptide.	191
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatment	191
Airway inflammation in healthy smokers	191
Efficacy and safety of surgical lung biopsy for interstitial disease. Experience of 161 consecutive patients from a single institution in Italy	189
Computerized patient record for a department of respiratory rehabilitation.	187
Recent developments in the diagnosis and management of tuberculosis	187
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?	186
An electronic nose in the discrimination of patients with asthma and controls	186
Prospects of rehabilitation in respiratory diseases	185
Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma	185
Heterogeneity of pulmonary rehabilitation: like apples and oranges - both healthy fruit	184
Italian survey on prevalence and disease management of chronic heart failure and chronic obstructive pulmonary disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design	184
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET	182
Development of a Barthel Index based on dyspnea for patients with respiratory diseases	182
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells	182
Chronic bronchial asthma from challenge to treatment: epidemiology and social impact	181
Management of drug resistantTB in patients with HIV co-infection	181
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients	181
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease	181
Towards a practical clinical use of fractioned exhaled nitric oxide levels in chronic cough	180
Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis	179
Asma Bronchiale.	178
Is bronchodilator the correct treatment for COPD subjects before EBUS?	177
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease	176
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease	176
SPUTUM AND EXHALED BREATH ANALYSIS	175
The new frontiers of rehabilitation medicine in people with chronic disabling illnesses	175
Genotyping of microsatellite alterations and EGFR somatic mutations in exhaled breath condensate of NSCLC patients	174
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: A non-inferiority, randomised, double-blind clinical trial	174
Assembly 5: Airway diseases	174
Totale	20.950

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	204.752
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	204.752

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	1.931	0	0	0	70	83	185	204	176	157	486	221	349
2022/2023	3.395	441	147	291	360	225	701	39	366	452	148	121	104
2023/2024	6.222	840	865	1.323	1.037	1.175	404	101	117	185	94	51	30
2024/2025	4.451	53	93	781	151	180	355	163	271	523	447	319	1.115
2025/2026	10.901	539	566	685	1.167	703	520	2.556	682	1.351	786	694	652
2026/2027	3.647	398	553	1.444	1.252	0	0	0	0	0	0	0	0
Totale													46.801